TY - JOUR T1 - A Novel Olfactory Self-Test Effectively Screens for COVID-19 JF - medRxiv DO - 10.1101/2021.02.18.21251422 SP - 2021.02.18.21251422 AU - Kobi Snitz AU - Danielle Honigstein AU - Reut Weissgross AU - Aharon Ravia AU - Eva Mishor AU - Ofer Perl AU - Shiri Karagach AU - Abebe Medhanie AU - Nir Harel AU - Sagit Shushan AU - Yehudah Roth AU - Behzad Iravani AU - Artin Arshamian AU - Gernot Ernst AU - Masako Okamoto AU - Cindy Poo AU - Niccolò Bonacchi AU - Zachary Mainen AU - Erminio Monteleone AU - Caterina Dinnella AU - Sara Spinelli AU - Franklin Mariño-Sánchez AU - Camille Ferdenzi AU - Monique Smeets AU - Kazushige Touhara AU - Moustafa Bensafi AU - Thomas Hummel AU - Johan N. Lundström AU - Noam Sobel Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/26/2021.02.18.21251422.abstract N2 - Key to curtailing the COVID-19 pandemic are wide-scale testing strategies1,2. An ideal test is one that would not rely on transporting, distributing, and collecting physical specimens. Given the olfactory impairment associated with COVID-193-7, we developed a novel measure of olfactory perception that relies on smelling household odorants and rating them online. We tested the performance of this real-time tool in 12,020 participants from 134 countries who provided 171,500 perceptual ratings of 60 different household odorants. We observed that olfactory ratings were indicative of COVID-19 status in a country, significantly correlating with national infection rates over time. More importantly, we observed remarkable indicative power at the individual level (90% sensitivity and 80% specificity). Critically, olfactory testing remained highly effective in participants with COVID-19 but without symptoms, and in participants with symptoms but without COVID-19. In this, the current odorant-based olfactory test stands apart from symptom-checkers (including olfactory symptom-checkers)3, and even from antigen tests8, to potentially provide a first line of screening that can help halt disease progression at the population level.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by a Weizmann CoronaVirus Emergency Fund grant from Miel de Botton and a Weizmann CoronaVirus Emergency Fund grant from Sonia T. Marschak.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Weizmann Institute of Science IRB committee, and by the Wolfson Hospital Helsinki CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data as well as matlab files are attached. code for processing creating the figures is available. https://gitlab.com/snitz/smelltracker_article ER -